Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Recommendation of “Hold” from Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have earned a consensus recommendation of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation. The average twelve-month target price among brokerages that have covered the stock in the last year is $25.00.

A number of equities research analysts recently weighed in on the stock. Truist Financial lifted their price objective on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and upped their price target for the stock from $27.00 to $28.00 in a research note on Wednesday, August 19th. Weiss Ratings lowered shares of Pediatrix Medical Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 25th. UBS Group increased their price target on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Finally, Mizuho set a $24.00 price objective on Pediatrix Medical Group in a report on Friday, May 8th.

Pediatrix Medical Group Stock Up 0.2%

Pediatrix Medical Group stock opened at $26.66 on Monday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.32. Pediatrix Medical Group has a one year low of $15.69 and a one year high of $27.94. The company has a 50-day simple moving average of $26.06 and a 200-day simple moving average of $23.19. The firm has a market capitalization of $2.17 billion, a P/E ratio of 12.76 and a beta of 0.66.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.59 by $0.04. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.The firm had revenue of $487.78 million for the quarter, compared to analysts’ expectations of $478.49 million. During the same period last year, the firm earned $0.53 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. As a group, equities analysts expect that Pediatrix Medical Group will post 2.17 earnings per share for the current year.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of hedge funds have recently modified their holdings of MD. BlackRock Inc. purchased a new position in Pediatrix Medical Group in the 2nd quarter worth about $347,383,000. Dimensional Fund Advisors LP raised its stake in shares of Pediatrix Medical Group by 8.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,856,915 shares of the company’s stock worth $82,496,000 after purchasing an additional 287,696 shares in the last quarter. California State Teachers Retirement System raised its position in Pediatrix Medical Group by 3,906.1% during the second quarter. California State Teachers Retirement System now owns 3,282,109 shares of the company’s stock valued at $83,136,000 after acquiring an additional 3,200,181 shares in the last quarter. Wasatch Advisors LP raised its holdings in shares of Pediatrix Medical Group by 21.9% during the 2nd quarter. Wasatch Advisors LP now owns 2,498,884 shares of the company’s stock valued at $63,297,000 after purchasing an additional 448,360 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in Pediatrix Medical Group by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 2,181,712 shares of the company’s stock valued at $46,674,000 after buying an additional 14,421 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.